As the global economy recovers in 2021 and the supply of the industrial chain improves, the CRM197 market will undergo major changes. According to the latest research, the market size of the CRM197 industry in 2021 will increase by USD million compared to 2020, with a growth rate of %.
The global CRM197 industry report provides top-notch qualitative and quantitative information including: Market size (2017-2021 value and 2022 forecast). The report also contains descriptions of key players, including key financial indicators and market competitive pressure analysis.
The report also assesses key opportunities in the market and outlines the factors that are and will drive the growth of the industry. Taking into account previous growth patterns, growth drivers, and current and future trends, we also forecast the overall growth of the global CRM197 market during the next few years. The global CRM197 market size will reach USD million in 2028, growing at a CAGR of % during the analysis period.
This report presents a comprehensive overview, market shares, and growth opportunities of CRM197 market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Research Grade CRM197
cGMP Grade CRM197
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Pneumococcal Conjugate Vaccine
Meningococcal Polysaccharide Conjugate Vaccine
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Pfizer Inc.
Ligand Pharmaceuticals
CanSino Biologic
Beijing Kexing Biology Product
Scarab Genomics
Xpress Biologics
Fina Biosolutions
Eubiologics
EirGenix Inc.
Table of Content
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global CRM197 Market Size 2017-2028
2.1.2 CRM197 Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 CRM197 Segment by Type
2.2.1 Research Grade CRM197
2.2.2 cGMP Grade CRM197
2.3 CRM197 Market Size by Type
2.3.1 CRM197 Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global CRM197 Market Size Market Share by Type (2017-2022)
2.4 CRM197 Segment by Application
2.4.1 Pneumococcal Conjugate Vaccine
2.4.2 Meningococcal Polysaccharide Conjugate Vaccine
2.4.3 Others
2.5 CRM197 Market Size by Application
2.5.1 CRM197 Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global CRM197 Market Size Market Share by Application (2017-2022)
3 CRM197 Market Size by Player
3.1 CRM197 Market Size Market Share by Players
3.1.1 Global CRM197 Revenue by Players (2020-2022)
3.1.2 Global CRM197 Revenue Market Share by Players (2020-2022)
3.2 Global CRM197 Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CRM197 by Regions
4.1 CRM197 Market Size by Regions (2017-2022)
4.2 Americas CRM197 Market Size Growth (2017-2022)
4.3 APAC CRM197 Market Size Growth (2017-2022)
4.4 Europe CRM197 Market Size Growth (2017-2022)
4.5 Middle East & Africa CRM197 Market Size Growth (2017-2022)
5 Americas
5.1 Americas CRM197 Market Size by Country (2017-2022)
5.2 Americas CRM197 Market Size by Type (2017-2022)
5.3 Americas CRM197 Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CRM197 Market Size by Region (2017-2022)
6.2 APAC CRM197 Market Size by Type (2017-2022)
6.3 APAC CRM197 Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe CRM197 by Country (2017-2022)
7.2 Europe CRM197 Market Size by Type (2017-2022)
7.3 Europe CRM197 Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa CRM197 by Region (2017-2022)
8.2 Middle East & Africa CRM197 Market Size by Type (2017-2022)
8.3 Middle East & Africa CRM197 Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global CRM197 Market Forecast
10.1 Global CRM197 Forecast by Regions (2023-2028)
10.1.1 Global CRM197 Forecast by Regions (2023-2028)
10.1.2 Americas CRM197 Forecast
10.1.3 APAC CRM197 Forecast
10.1.4 Europe CRM197 Forecast
10.1.5 Middle East & Africa CRM197 Forecast
10.2 Americas CRM197 Forecast by Country (2023-2028)
10.2.1 United States CRM197 Market Forecast
10.2.2 Canada CRM197 Market Forecast
10.2.3 Mexico CRM197 Market Forecast
10.2.4 Brazil CRM197 Market Forecast
10.3 APAC CRM197 Forecast by Region (2023-2028)
10.3.1 China CRM197 Market Forecast
10.3.2 Japan CRM197 Market Forecast
10.3.3 Korea CRM197 Market Forecast
10.3.4 Southeast Asia CRM197 Market Forecast
10.3.5 India CRM197 Market Forecast
10.3.6 Australia CRM197 Market Forecast
10.4 Europe CRM197 Forecast by Country (2023-2028)
10.4.1 Germany CRM197 Market Forecast
10.4.2 France CRM197 Market Forecast
10.4.3 UK CRM197 Market Forecast
10.4.4 Italy CRM197 Market Forecast
10.4.5 Russia CRM197 Market Forecast
10.5 Middle East & Africa CRM197 Forecast by Region (2023-2028)
10.5.1 Egypt CRM197 Market Forecast
10.5.2 South Africa CRM197 Market Forecast
10.5.3 Israel CRM197 Market Forecast
10.5.4 Turkey CRM197 Market Forecast
10.5.5 GCC Countries CRM197 Market Forecast
10.6 Global CRM197 Forecast by Type (2023-2028)
10.7 Global CRM197 Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Information
11.1.2 Pfizer Inc. CRM197 Product Offered
11.1.3 Pfizer Inc. CRM197 Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Pfizer Inc. Main Business Overview
11.1.5 Pfizer Inc. Latest Developments
11.2 Ligand Pharmaceuticals
11.2.1 Ligand Pharmaceuticals Company Information
11.2.2 Ligand Pharmaceuticals CRM197 Product Offered
11.2.3 Ligand Pharmaceuticals CRM197 Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Ligand Pharmaceuticals Main Business Overview
11.2.5 Ligand Pharmaceuticals Latest Developments
11.3 CanSino Biologic
11.3.1 CanSino Biologic Company Information
11.3.2 CanSino Biologic CRM197 Product Offered
11.3.3 CanSino Biologic CRM197 Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 CanSino Biologic Main Business Overview
11.3.5 CanSino Biologic Latest Developments
11.4 Beijing Kexing Biology Product
11.4.1 Beijing Kexing Biology Product Company Information
11.4.2 Beijing Kexing Biology Product CRM197 Product Offered
11.4.3 Beijing Kexing Biology Product CRM197 Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Beijing Kexing Biology Product Main Business Overview
11.4.5 Beijing Kexing Biology Product Latest Developments
11.5 Scarab Genomics
11.5.1 Scarab Genomics Company Information
11.5.2 Scarab Genomics CRM197 Product Offered
11.5.3 Scarab Genomics CRM197 Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Scarab Genomics Main Business Overview
11.5.5 Scarab Genomics Latest Developments
11.6 Xpress Biologics
11.6.1 Xpress Biologics Company Information
11.6.2 Xpress Biologics CRM197 Product Offered
11.6.3 Xpress Biologics CRM197 Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Xpress Biologics Main Business Overview
11.6.5 Xpress Biologics Latest Developments
11.7 Fina Biosolutions
11.7.1 Fina Biosolutions Company Information
11.7.2 Fina Biosolutions CRM197 Product Offered
11.7.3 Fina Biosolutions CRM197 Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Fina Biosolutions Main Business Overview
11.7.5 Fina Biosolutions Latest Developments
11.8 Eubiologics
11.8.1 Eubiologics Company Information
11.8.2 Eubiologics CRM197 Product Offered
11.8.3 Eubiologics CRM197 Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Eubiologics Main Business Overview
11.8.5 Eubiologics Latest Developments
11.9 EirGenix Inc.
11.9.1 EirGenix Inc. Company Information
11.9.2 EirGenix Inc. CRM197 Product Offered
11.9.3 EirGenix Inc. CRM197 Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 EirGenix Inc. Main Business Overview
11.9.5 EirGenix Inc. Latest Developments
12 Research Findings and Conclusion
Pfizer Inc.
Ligand Pharmaceuticals
CanSino Biologic
Beijing Kexing Biology Product
Scarab Genomics
Xpress Biologics
Fina Biosolutions
Eubiologics
EirGenix Inc.
*If Applicable.